1BA Subcutaneous Administration of Trastuzumab in Patients with HER2-positive Early Breast Cancer: Results From the Phase III Randomised, Open-label, Multi-centre Neoadjuvant-adjuvant HannaH Study

✍ Scribed by C. Jackisch; D. Stroyakovskiy; S. Muehlbauer; D. Heinzmann; M.V. Kopp; J.S. Ahn; E. Staroslawska; S. Falcon; X. Pivot; G. Ismael

• Book ID: 117661913
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 58 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)70068-0